Haemonetics CFO Burke to retire June 2022; retention bonus up to 50% of base salary

HAEMONETICS CORP

CFO William P. Burke to retire in June 2022; will remain in role and assist transition until then.
Retention bonus: 25% of base salary if new CFO starts before Apr 2, 2022; 50% if after.
Burke also to receive pro rata FY2023 bonus if retained through June 30, 2022.
Company issued Q2 FY2022 earnings press release (no financial details available in this filing).

item 2.02 item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

William P. Burke

Executive Vice President, Chief Financial Officer

HAE · HAEMONETICS CORP

Effective: 2022-06-30
Filed: November 9, 2021, 6:59 PM ET

William P. Burke, Executive Vice President, Chief Financial Officer (“CFO”) has decided to retire from the Company in June 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

William P. Burke departed as Executive Vice President, Chief Financial Officer at HAEMONETICS CORP.

Action: retire
Role: Executive Vice President, Chief Financial Officer

Exact text from the filing

William P. Burke, Executive Vice President, Chief Financial Officer (“CFO”) has decided to retire from the Company in June 2022.

View on SEC.gov

HAEMONETICS CORP filing history →

Source: SEC EDGAR

accession 0000313143-21-000050

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.